These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Urinary Extracellular Domain of Neurotrophin Receptor p75 as a Biomarker for Amyotrophic Lateral Sclerosis in a Chinese cohort. Jia R; Shepheard S; Jin J; Hu F; Zhao X; Xue L; Xiang L; Qi H; Qu Q; Guo F; Rogers ML; Dang J Sci Rep; 2017 Jul; 7(1):5127. PubMed ID: 28698670 [TBL] [Abstract][Full Text] [Related]
6. Ratio of urinary N-terminal titin fragment to urinary creatinine is a novel biomarker for amyotrophic lateral sclerosis. Yamada S; Hashizume A; Hijikata Y; Ito D; Kishimoto Y; Iida M; Koike H; Hirakawa A; Katsuno M J Neurol Neurosurg Psychiatry; 2021 Oct; 92(10):1072-1079. PubMed ID: 33737450 [TBL] [Abstract][Full Text] [Related]
7. Urinary neopterin, a new marker of the neuroinflammatory status in amyotrophic lateral sclerosis. Lunetta C; Lizio A; Gerardi F; Tarlarini C; Filippi M; Riva N; Tremolizzo L; Diamanti S; Dellanoce CC; Mosca L; Sansone VA; Campolo J J Neurol; 2020 Dec; 267(12):3609-3616. PubMed ID: 32638112 [TBL] [Abstract][Full Text] [Related]
8. Venous creatinine as a biomarker for loss of fat-free mass and disease progression in patients with amyotrophic lateral sclerosis. Holdom CJ; Janse van Mantgem MR; van Eijk RPA; Howe SL; van den Berg LH; McCombe PA; Henderson RD; Ngo ST; Steyn FJ Eur J Neurol; 2021 Nov; 28(11):3615-3625. PubMed ID: 34216521 [TBL] [Abstract][Full Text] [Related]
9. Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis. Patin F; Corcia P; Madji Hounoum B; Veyrat-Durebex C; Respaud E; Piver E; Benz-de Bretagne I; Vourc'h P; Andres CR; Blasco H Eur J Neurol; 2015 Oct; 22(10):1385-90. PubMed ID: 26095828 [TBL] [Abstract][Full Text] [Related]
10. Protein biomarkers for the diagnosis and prognosis of Amyotrophic Lateral Sclerosis. Donini L; Tanel R; Zuccarino R; Basso M Neurosci Res; 2023 Dec; 197():31-41. PubMed ID: 37689321 [TBL] [Abstract][Full Text] [Related]
11. Plasma creatinine and amyotrophic lateral sclerosis prognosis: a systematic review and meta-analysis. Lanznaster D; Bejan-Angoulvant T; Patin F; Andres CR; Vourc'h P; Corcia P; Blasco H Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):199-206. PubMed ID: 30961401 [No Abstract] [Full Text] [Related]
12. Serum asymmetric dimethylarginine level correlates with the progression and prognosis of amyotrophic lateral sclerosis. Ikenaka K; Maeda Y; Hotta Y; Nagano S; Yamada S; Ito D; Torii R; Kakuda K; Tatebe H; Atsuta N; Aguirre C; Kimura Y; Baba K; Tokuda T; Katsuno M; Kimura K; Sobue G; Mochizuki H Eur J Neurol; 2022 May; 29(5):1410-1416. PubMed ID: 35128793 [TBL] [Abstract][Full Text] [Related]
14. Tau protein as a diagnostic and prognostic biomarker in amyotrophic lateral sclerosis. Agnello L; Colletti T; Lo Sasso B; Vidali M; Spataro R; Gambino CM; Giglio RV; Piccoli T; Bivona G; La Bella V; Ciaccio M Eur J Neurol; 2021 Jun; 28(6):1868-1875. PubMed ID: 33638255 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal comparison of the self-entry Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-RSE) and Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) as outcome measures in people with amyotrophic lateral sclerosis. Johnson SA; Burke KM; Scheier ZA; Keegan MA; Clark AP; Chan J; Fournier CN; Berry JD Muscle Nerve; 2022 Oct; 66(4):495-502. PubMed ID: 35904151 [TBL] [Abstract][Full Text] [Related]